1. Cheng-Ching E, Samaniego EA, Naravetla BR, Zaidat OO, Hussain MS. Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics. Neurology. 2012;79(13 Suppl 1):S68–76.
2. Agarwal S, Abdelmotieleb M. Viscoelastic testing in cardiac surgery. Transfusion. 2020;60(Suppl 6):S52–60.
3. Loyaga-Rendon RY, Kazui T, Acharya D. Antiplatelet and anticoagulation strategies for left ventricular assist devices. Ann Transl Med. 2020:1–17. https://doi.org/10.21037/atm-20-4849. Epub ahead of print.
4. Slaughter MS, Naka Y, John R, et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. JHLT. 2010;29(6):616–24.
5. Sheikh FH, Peters LM, Grinstein J, et al. Feasibility of delayed parenteral heparin initiation after HM3 implantation. JHLT. 2020;39(4):S450.